trial · primary record
Asparaginase Erwinia chrysanthemi
Acute Leukemia of Ambiguous Lineage
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 153 |
| Primary completion | 2028-12-31 |
| Primary endpoint | Incidence of dose-limiting toxicities (DLTs) (safety phase) |
| Registry ID | NCT06317662 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:46.830Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06317662
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.